Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2026 Earnings Call Transcript May 13, 2026
Protalix BioTherapeutics, Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $-0.01.
Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2026 Financial and Business Results Conference Call. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Mike Moyer of LifeSci Advisors,...
